You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Castration-resistant prostate cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial (MK-5684, Dexamethasone, Fludrocortisone acetate)

Not yet recruiting
  • Prostatic Neoplasms
  • Metastatic Castration-Resistant Prostate Cancer
  • (no location specified)
Oct 23, 2023

Metastatic Castration-resistant Prostate Cancer Trial (ONCT-534)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • (no location specified)
Jun 15, 2023

Metastatic Castration-resistant Prostate Cancer Trial in Salt Lake City (Bortezomib)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Salt Lake City, Utah
    Huntsman Cancer Institute/University of Utah
Sep 7, 2023

Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial (MK-5684, Dexamethasone, Fludrocortisone)

Not yet recruiting
  • Prostatic Neoplasms
  • Metastatic Castration-Resistant Prostate Cancer
  • (no location specified)
Nov 13, 2023

Castration-Resistant Prostatic Cancer Trial ([Lu-177]-PNT2002)

Available
  • Castration-Resistant Prostatic Cancer
  • (no location specified)
Sep 11, 2023

Advanced Prostate Cancer Trial (HRS-5041)

Not yet recruiting
  • Advanced Prostate Cancer
  • (no location specified)
Jul 5, 2023

Metastatic Castration Resistant Prostate Cancer Trial in London (IMU-935)

Recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • London, United Kingdom
    Institute of Cancer Research
Jan 31, 2023

Metastasis Castration Resistant Prostate Cancer(mCRPC) Trial (HS-20093)

Not yet recruiting
  • Metastasis Castration Resistant Prostate Cancer(mCRPC)
  • (no location specified)
Aug 14, 2023

Castrate Resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in San Francisco

Not yet recruiting
  • Castrate Resistant Prostate Cancer
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Mar 1, 2023

Prostate-Specific Membrane Antigen (PSMA) Radionuclide Therapy

Recruiting
  • PSMA-positive Metastatic Castration-resistant Prostate Cancer Treated With PSMA Radionuclide Therapy
  • PSMA radionuclide therapy
  • Dallas, Texas
    Methodist Dallas Medical Center
Aug 9, 2023

Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Tumors Trial (MK-5684, Dexamethasone, Fludrocortisone

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer (mCRPC)
  • Prostatic Neoplasms
  • (no location specified)
Nov 21, 2023

Prospective Androgen Receptor Signaling Inhibitors Resistance

Not yet recruiting
  • Prostate Cancer
  • +3 more
    • (no location specified)
    Nov 15, 2023

    Metastatic Castration-resistant Prostate Cancer Trial in Salt Lake City (Enfortumab vedotin)

    Recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • Enfortumab vedotin
    • Salt Lake City, Utah
      Huntsman Cancer Institute
    Jan 24, 2023

    Darolutamide, Enzalutamide and Apalutamide and How Well These

    Not yet recruiting
    • Non-metastatic Castration-resistant Prostate Cancer
    • Whippany, New Jersey
      Bayer
    Aug 25, 2023

    Metastatic Castration-resistant Prostate Cancer Trial (Disitamab Vedotin(RC48-ADC))

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • Disitamab Vedotin（RC48-ADC）
    • (no location specified)
    Jul 13, 2023

    Castration-Resistant Prostate Cancer Trial (SHR3680 tablets)

    Not yet recruiting
    • Castration-Resistant Prostate Cancer
    • SHR3680 tablets
    • (no location specified)
    Nov 1, 2022

    Metastatic Castration-resistant Prostate Cancer Trial in United States (BMS-986460)

    Recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • Palo Alto, California
    • +7 more
    Oct 10, 2023

    Hormone-refractory Prostate Cancer Trial (AMX-500)

    Not yet recruiting
    • Hormone-refractory Prostate Cancer
    • (no location specified)
    Aug 11, 2023

    Prostate Cancer Trial in Beijing, Nanjing (QLH12016)

    Not yet recruiting
    • Prostate Cancer
    • Beijing, Beijign, China
    • +1 more
    Jul 25, 2023

    Prostatic Tumors, Castration-Resistant Trial in Multiple Locations (Radium-223 dichloride (Xofigo, BAY 88-8223))

    Active, not recruiting
    • Prostatic Neoplasms, Castration-Resistant
    • Radium-223 dichloride (Xofigo, BAY 88-8223)
    • Multiple Locations, Japan
      (unnamed)
    Feb 2, 2023

    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial in Oklahoma City (Sipuleucel-T)

    Not yet recruiting
    • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
    • Sipuleucel-T
    • Oklahoma City, Oklahoma
      Stephenson's Cancer Center
    Mar 28, 2023

    Metastatic Castration-resistant Prostate Cancer Trial in New Haven (Testosterone Cypionate, Sipuleucel-T)

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • New Haven, Connecticut
      Yale Cancer Center
    Oct 20, 2023

    PRostate Olaparib Real World Evidence Study

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Cancer
      • (no location specified)
      Sep 4, 2023

      Medicines Called Enzalutamide and Abiraterone in People With

      Not yet recruiting
      • Prostatic Neoplasms, Castration-Resistant
      • New York, New York
        Pfizer Inc
      Jul 21, 2023

      Metastatic Castration-resistant Prostate Cancer, mCRPC Trial in Seoul ([177Lu]Ludotadipep)

      Recruiting
      • Metastatic Castration-resistant Prostate Cancer, mCRPC
      • Seoul, Korea, Republic of
        The Catholic University of Korea, Seoul, St, Mary's Hospital, 22
      Dec 8, 2022